2-(N-thiocarbamoylimino)-hexahydropyrimidine | 88964-74-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 2-(N-thiocarbamoylimino)-hexahydropyrimidine
• 英文别名: N-(2-Tetrahydropyrimidinyliden)-thioharnstoff；1-(tetrahydropyrimidin-2(1H)-ylidene)thiourea；(tetrahydro-pyrimidin-2-ylidene)-thiourea；(3,4,5,6-tetrahydropyrimidin-2(1H)-ylidene)-thiourea；N-(1,4,5,6-Tetrahydropyrimidin-2-yl)thiourea；1,4,5,6-tetrahydropyrimidin-2-ylthiourea
• CAS: 88964-74-3
• 化学式: C₅H₁₀N₄S
• 分子量: 158.227
• InChiKey: GPXBOCGVCICQNK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.8
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  94.5
• 氢给体数：
  3
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(N-thiocarbamoylimino)-hexahydropyrimidine 在 一水合肼 作用下， 以 乙醇 、 丙酮 为溶剂， 反应 9.0h， 生成 3-<(3,4,5,6-Tetrahydropyrimidin-2(1H)-yliden)aminothiazol-4-yl>propylamin
  参考文献：
  名称：

  Buschauer, Arzneimittel-Forschung/Drug Research, 1987, vol. 37, # 9, p. 1003 - 1007

  摘要：

  DOI：
• 作为产物：
  描述：

  2-Cyaniminoperhydropyrimidin 在 硫化氢 、 potassium hydrosulfide 作用下， 以 甲醇 为溶剂， 反应 16.0h， 以80%的产率得到2-(N-thiocarbamoylimino)-hexahydropyrimidine
  参考文献：
  名称：

  Trumm; Sattler; Postius, Arzneimittel-Forschung/Drug Research, 1985, vol. 35, # 3, p. 573 - 577

  摘要：

  DOI：
• 作为试剂：
  描述：

  2-(N-thiocarbamoylimino)-hexahydropyrimidine 、 2-bromo-1-(2-(2,4-dimethylphenoxy)phenyl)ethan-1-one 在 2-(N-thiocarbamoylimino)-hexahydropyrimidine 作用下， 以75的产率得到阿巴芬净
  参考文献：
  名称：

  Journal of labelled compounds and radiopharmaceuticals 1995, 36, 275-279

  摘要：

  DOI：

文献信息

• Antimycotically active substituted 2-aminothiazoles
  申请人：Bayer Aktiengesellschaft

  公开号：US05104879A1

  公开（公告）日：1992-04-14

  Antimicotically active 2-aminothiazoles have been found having the formula ##STR1## in which R.sup.1 represents hydrogen or alkyl and R.sup.2 represents optionally substituted cyclohexyl or phenyl which is substituted by halogen, alkyl, halogenoalkyl, halogenoalkoxy, dioxyhalogenoalkyl or halogenoalkylthio, and their physiologically tolerable acid addition salts, with the exception of the compounds 4-(4-chlorophenyl)-2-[2-(1,4,5,6-tetrahydropyrimidinyl)-amino]thiazole and 4-(2,4-dichlorophenyl)-2-[2-(1,4,5,6-tetrahydropyrimidinyl)-amino]-thiazol e and 4-(4-chloro-2-methylphenyl)-2-[2-(1,4,5,6-tetrahydropyrimidinyl)-amino]-th iazole and with the exception of the physiologically tolerable acid addition salts of these compounds have been found.

  已发现具有下列公式的抗真菌活性2-氨基噻唑：其中R.sup.1代表氢或烷基，R.sup.2代表可选地被取代的环己基或苯基，其被卤素、烷基、卤代烷基、卤代烷氧基、二氧卤代烷基或卤代烷基硫取代，并且它们的生理耐受性酸盐，除了已发现的化合物4-(4-氯苯基)-2-[2-(1,4,5,6-四氢嘧啶基)-氨基]噻唑和4-(2,4-二氯苯基)-2-[2-(1,4,5,6-四氢嘧啶基)-氨基]-噻唑和4-(4-氯-2-甲基苯基)-2-[2-(1,4,5,6-四氢嘧啶基)-氨基]-噻唑以及这些化合物的生理耐受性酸盐。
• Thiazole derivatives
  申请人：Hoffmann-La Roche Inc.

  公开号：US06344562B1

  公开（公告）日：2002-02-05

  Compounds of the formula: as well as pharmaceutically usable salts and esters thereof, wherein R1, R2 and R3 have the significance ascribed herein, inhibit binding of adhesive proteins to the surface of different types of cell and accordingly influence cell-cell and cell-matrix interactions. These compounds can be used in the form of pharmaceutical preparations for the control or prevention of neoplasms, tumor metastasing, tumor growth, osteoporosis, Paget's disease, diabetic retinopathy, macular degeneration, restenosis following vascular intervention, psoriasis, arthritis, fibrosis, kidney failure, as well as infection caused by viruses, bacteria or fungi.

  该公式的化合物：以及其药用盐和酯，其中R1、R2和R3具有在此规定的意义，抑制粘附蛋白质与不同类型细胞表面的结合，从而影响细胞-细胞和细胞-基质相互作用。这些化合物可以用作制药制剂的形式，用于控制或预防肿瘤、肿瘤转移、肿瘤生长、骨质疏松症、帕盖特病、糖尿病视网膜病变、黄斑变性、血管介入后再狭窄、银屑病、关节炎、纤维化、肾功能衰竭，以及由病毒、细菌或真菌引起的感染。
• Pyrimidinone antibiotics—heterocyclic analogues with improved antibacterial spectrum
  作者：Michael Brands、Yolanda Cancho Grande、Rainer Endermann、Reinhold Gahlmann、Jochen Krüger、Siegfried Raddatz

  DOI：10.1016/s0960-894x(03)00578-x

  日期：2003.8

  We report the synthesis and pharmacological evaluation of new derivatives of the natural dipeptide antibiotic TAN 1057 A,B containing heterocycles either in the beta-amino acid side chain or as mimics of the urea function. In the course of this program, we identified novel analogues that display activity towards a broader panel of Gram-positive bacteriae.

  我们报告了天然二肽抗生素TAN 1057 A，B的新衍生物的合成和药理学评估，该衍生物在β-氨基酸侧链中或作为尿素功能的模拟物含有杂环。在该程序的过程中，我们确定了显示对更广泛的革兰氏阳性细菌具有活性的新型类似物。
• Identification of Thiazoyl Guanidine Derivatives as Novel Antifungal Agents Inhibiting Ergosterol Biosynthesis for Treatment of Invasive Fungal Infections
  作者：Issei Kato、Yuuta Ukai、Noriyasu Kondo、Kohei Nozu、Chiaki Kimura、Kumi Hashimoto、Eri Mizusawa、Hideki Maki、Akira Naito、Makoto Kawai

  DOI：10.1021/acs.jmedchem.1c00883

  日期：2021.7.22

  antifungal agents, which inhibit a novel target enzyme in the ergosterol biosynthesis pathway. Structure–activity relationship development and property optimization by reducing lipophilicity led to the discovery of 6h, which showed potent antifungal activity against Aspergillus fumigatus in the presence of serum, improved metabolic stability, and PK properties. In the murine systemic A. fumigatus infection

  侵袭性真菌感染 (IFIs) 是致命的感染，但治疗选择有限。由于副作用、药物相互作用、不利的药代动力学特征和新出现的耐药真菌，现有药物的临床疗效并不令人满意。因此，开发具有新机制的抗真菌药物是当务之急。在此，我们报告了新型芳基胍抗真菌剂，其抑制麦角甾醇生物合成途径中的新型靶酶。通过降低亲脂性的构效关系发展和性质优化导致了6h的发现，其在血清存在下显示出对烟曲霉的有效抗真菌活性，提高了代谢稳定性和 PK 特性。在小鼠全身A. fumigatus感染模型，6 小时表现出与伏立康唑相当的抗真菌功效 ( 1e )。此外，由于麦角甾醇生物合成途径中新靶点的抑制作用，6h显示出对耐唑类烟曲霉的抗真菌活性。
• Imidazolyl alkyl guanidine derivatives, processes for their preparation
  申请人：Heumann Pharma GmbH & Co.

  公开号：US05021431A1

  公开（公告）日：1991-06-04

  New imidazolylalkyl-guanidine derivatives are described, which by virtue of their agonistic action on histamine-H.sub.2 receptors and in part also due to their additional H.sub.1 -antagonistic receptor activity can be used in the treatment of cardiac diseases, certain forms of hypertension and diseases of arterial occlusion. These imidazolylalkyl-guanidine derivatives correspond to the general formula I: ##STR1##

  描述了一种新的咪唑基烷基胍衍生物，由于其在组胺-H.sub.2受体上的激动作用以及部分原因于其额外的H.sub.1-拮抗受体活性，可以用于治疗心脏疾病、某些形式的高血压和动脉闭塞性疾病。这些咪唑基烷基胍衍生物对应于通用公式I：##STR1##